Publications by authors named "Devraj Chakravarty"

Claim this Profile
S
Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists.
Brian C Shook, Devraj Chakravarty, J Kent Barbay, Aihua Wang, Kristi Leonard

Bioorg Med Chem Lett· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's disease.
Brian C Shook, Stefanie Rassnick, Nathaniel Wallace, Jeffrey Crooke, Mark Ault, Devraj Chakravarty

J Med Chem· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease.
Brian C Shook, Stefanie Rassnick, Melville C Osborne, Scott Davis, Lori Westover, Devraj Chakravarty

J Med Chem· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.
Brian C Shook, Stefanie Rassnick, Devraj Chakravarty, Nathaniel Wallace, Mark Ault

Bioorg Med Chem Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylene amine substituted arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.
Brian C Shook, Stefanie Rassnick, Daniel Hall, Kenneth C Rupert, Geoffrey R Heintzelman, Devraj Chakravarty

Bioorg Med Chem Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.
Yue-Mei Zhang, Xiaodong Fan, Bangping Xiang, Devraj Chakravarty, Robert Scannevin

Bioorg Med Chem Lett· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis